Eben Tessari Kiniksa Pharmaceuticals, Ltd. (KNSA) insider trading activity

KNSA Quotes by TradingView

Eben Tessari is CHIEF OPERATING OFFICER of Kiniksa Pharmaceuticals, Ltd.. Currently has a direct ownership of 44,452 shares of KNSA, which is worth approximately $1.64 Million. The most recent transaction as insider was on Mar 21, 2022, when has been sold 4,611 shares (Class A Common Share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 44.5K
38.57% 3M change
64.29% 12M change
Total Value Held $1.64 Million

Eben Tessari Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 21 2022
BUY
Exercise of conversion of derivative security
-
4,611 Added 3.9%
113,674 Class A Common Share
Mar 16 2022
SELL
Payment of exercise price or tax liability
$6,899 $10.13 p/Share
681 Reduced 0.62%
109,063 Class A Common Share
Mar 16 2022
BUY
Exercise of conversion of derivative security
-
1,964 Added 1.76%
109,744 Class A Common Share
Jan 15 2022
BUY
Grant, award, or other acquisition
$9,341 $9.63 p/Share
970 Added 0.89%
107,780 Class A Common Share
Jul 15 2021
BUY
Grant, award, or other acquisition
$9,973 $11.49 p/Share
868 Added 0.81%
106,810 Class A Common Share
ET

Eben Tessari

CHIEF OPERATING OFFICER
Hamilton, D0

Track Institutional and Insider Activities on KNSA

Follow Kiniksa Pharmaceuticals, Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KNSA shares.

Notify only if

Insider Trading

Get notified when an Kiniksa Pharmaceuticals, Ltd. insider buys or sells KNSA shares.

Notify only if

News

Receive news related to Kiniksa Pharmaceuticals, Ltd.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KNSA